Share This
Create Your Own Business Intelligence Website
 
Input the stock code or the company name     Search  

<06622.HK> - ZHAOKE OPHTHALMOLOGY LIMITED

 
 
 Basic Datum
Company name Lot P/E P/B EPS DPS
ZHAOKE OPHTH-B 500 -5.08 0.3794 -0.7783 0.0
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
02-21 HSBC  ZHAOKE OPHTH-B 69
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2022-03-28 兆科眼科(6622)今年內有望推出首款針對青光眼藥物,將開始錄得收入。他提到,隨著集團研發多款藥物進入三期臨床研究階段,料今年研發費用會大幅上升,但手上資金足夠應付未來兩至三年臨床研究所需。
 
2022-03-28 兆科眼科在乾眼症、近視及老花三大領域,已有產品完成三期臨床研究或在進行三期臨床研究中;研發亦兼顧角膜修復,並由眼表症狀,延伸到眼底如濕性老年黃斑部病變、糖尿病引發眼疾等方面部署。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 04-23 09:30 16682.7  171  1.04%
ZHAOKE OPHTH-B 04-25 16:09 1.54  1.54  ∞%
≫More
 
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.